A Mini Review on the Pathogenesis, Diagnosis and Treatment Options for COVID-19. 2022

Farzad Rahmani, and Aghigh Ziaeemehr, and Sajede Alijannejad, and Gordon A Ferns, and Majid Khazaei, and Soodabeh Shahidsales, and Amir Avan
Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Coronavirus disease 2019 (COVID-19) is a serious viral disease caused by SARS-CoV-2, associated with high morbidity and mortality, and represents a significant public health crisis worldwide. Despite recent efforts for developing novel antiviral agents, no specific drugs are approved for the management and treatment of COVID-19. The immune responses to viral infection followed by cytokine storm and acute respiratory distress syndrome are serious issues that may cause death in patients with severe COVID-19. Therefore, developing a novel therapeutic strategy for the management of COVID-19 is urgently needed to control the virus spread and to improve the patient survival rate and clinical outcomes. In this mini-review, we summarize the symptoms, pathogenesis, and therapeutic approaches currently being used to manage the spread of SARS-CoV-2.

UI MeSH Term Description Entries
D012128 Respiratory Distress Syndrome A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA. ARDS, Human,Acute Respiratory Distress Syndrome,Adult Respiratory Distress Syndrome,Pediatric Respiratory Distress Syndrome,Respiratory Distress Syndrome, Acute,Respiratory Distress Syndrome, Adult,Respiratory Distress Syndrome, Pediatric,Shock Lung,Distress Syndrome, Respiratory,Distress Syndromes, Respiratory,Human ARDS,Lung, Shock,Respiratory Distress Syndromes,Syndrome, Respiratory Distress
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000093485 COVID-19 Drug Treatment The use of DRUGS to treat COVID19 or its symptoms. COVID-19 Drug Therapy,COVID19 Drug Therapy,COVID19 Drug Treatment,Coronavirus Disease 2019 Drug Treatment,Coronavirus Disease-19 Drug Treatment,COVID 19 Drug Therapy,COVID 19 Drug Treatment,COVID-19 Drug Therapies,COVID19 Drug Therapies,COVID19 Drug Treatments,Coronavirus Disease 19 Drug Treatment,Drug Therapy, COVID-19,Drug Therapy, COVID19,Therapy, COVID-19 Drug,Therapy, COVID19 Drug,Treatment, COVID-19 Drug
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

Farzad Rahmani, and Aghigh Ziaeemehr, and Sajede Alijannejad, and Gordon A Ferns, and Majid Khazaei, and Soodabeh Shahidsales, and Amir Avan
January 2020, Revista da Sociedade Brasileira de Medicina Tropical,
Farzad Rahmani, and Aghigh Ziaeemehr, and Sajede Alijannejad, and Gordon A Ferns, and Majid Khazaei, and Soodabeh Shahidsales, and Amir Avan
January 2020, Frontiers in medicine,
Farzad Rahmani, and Aghigh Ziaeemehr, and Sajede Alijannejad, and Gordon A Ferns, and Majid Khazaei, and Soodabeh Shahidsales, and Amir Avan
June 2020, African journal of reproductive health,
Farzad Rahmani, and Aghigh Ziaeemehr, and Sajede Alijannejad, and Gordon A Ferns, and Majid Khazaei, and Soodabeh Shahidsales, and Amir Avan
September 2023, Cancer reports (Hoboken, N.J.),
Farzad Rahmani, and Aghigh Ziaeemehr, and Sajede Alijannejad, and Gordon A Ferns, and Majid Khazaei, and Soodabeh Shahidsales, and Amir Avan
January 2024, Frontiers in microbiology,
Farzad Rahmani, and Aghigh Ziaeemehr, and Sajede Alijannejad, and Gordon A Ferns, and Majid Khazaei, and Soodabeh Shahidsales, and Amir Avan
January 2021, Biologia,
Farzad Rahmani, and Aghigh Ziaeemehr, and Sajede Alijannejad, and Gordon A Ferns, and Majid Khazaei, and Soodabeh Shahidsales, and Amir Avan
January 2021, Microbial pathogenesis,
Farzad Rahmani, and Aghigh Ziaeemehr, and Sajede Alijannejad, and Gordon A Ferns, and Majid Khazaei, and Soodabeh Shahidsales, and Amir Avan
September 2020, Cureus,
Farzad Rahmani, and Aghigh Ziaeemehr, and Sajede Alijannejad, and Gordon A Ferns, and Majid Khazaei, and Soodabeh Shahidsales, and Amir Avan
August 2021, Respirology (Carlton, Vic.),
Farzad Rahmani, and Aghigh Ziaeemehr, and Sajede Alijannejad, and Gordon A Ferns, and Majid Khazaei, and Soodabeh Shahidsales, and Amir Avan
August 2013, International journal of molecular medicine,
Copied contents to your clipboard!